Expression and prognostic value of transcription factor PROX1 in colorectal cancer

British Journal of Cancer

Volumn 105, Issue 9, 2011, Pages 1346-1351

  Skog, M ^a,b   Bono, P ^a,b   Lundin, M ^b   Lundin, J ^b   Louhimo, J ^a   Linder, N ^b   Petrova, T V ^b   Andersson, L C ^c   Joensuu, H ^a,b   Alitalo, K ^b,c   Haglund, C H ^a,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

colorectal cancer; expression; prognosis; prospero related homeobox gene; PROX1

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; COLORECTAL NEOPLASMS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 80054998429     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.297     Document Type: Article

References (22)

1. Betschinger J, Mechtler K, Knoblich JA (2006) Asymmetric segregation of the tumour suppressor brat regulates self-renewal in Drosophila neural stem cells. Cell 124: 1241-1253
2. Birkenkamp-Demtroder K, Olesen SH, Sørensen FB, Laurberg S, Laiho P, Aaltonen LA, Orntoft TF (2005) Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54: 374-384 (Pubitemid 40299094)
3. Distler P, Holt PR (1997) Are right-and left-sided colon neoplasms distinct tumours? Dig Dis 15: 302-311 (Pubitemid 127522070)
4. Dyer MA, Livesey FJ, Cepko CL, Oliver G (2003) PROX1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retina. Nat Genet 34: 53-58 (Pubitemid 36548790)
5. Elsir T, Eriksson A, Orrego A, Lindström MS, Nistér M (2010) Expression of PROX1 is a common feature of high-grade malignant astrocytic gliomas. J Neuropathol Exp Neurol 69: 129-138
6. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, DeNobile J, Soballe P, Simon R, Wright G, Lynch P, Patterson S, Lynch H, Gallinger S, Buchbinder A, Gordon G, Hawk E, Kirsch IR (2003) Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 12: 755-762 (Pubitemid 36993166)
7. Iacopetta B (2002) Are there two sides to colorectal cancer? Int J Cancer 101: 403-408
8. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170 (Pubitemid 26358996)
9. Laerm A, Helmbold P, Goldberg M, Dammann R, Holzhausen HJ, Ballhausen WG (2007) Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletion and epigenetic silencing in carcinomas of the bilary system. J Hepatol 46: 89-97 (Pubitemid 44834428)
10. Li L, Vaessin H (2000) Pan-neural Prospero terminates cell proliferation during Drosophila neurogenesis. Genes Dev 14: 147-151 (Pubitemid 30070979)
11. Linder N, Martelin E, Lundin M, Louhimo J, Nordling S, Haglund C, Lundin J (2009) Xanthine oxidoreductase-Clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells. Eur J Cancer 45: 648-655
12. Meguin RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N (2008) Is there a difference in survival between right-versus left-sided colon cancers? Ann Surg Oncol 15: 2388-2394
13. Oliver G, Sosa-Pineda B, Geisendorf S, Spana EP, Doe CQ, Gruss P (1993) PROX1, a prospero-related homeobox gene expressed during mouse development. Mech Dev 44: 3-16 (Pubitemid 24037694)
14. Parkin D, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108 (Pubitemid 40372904)
15. Petrova TV, Nykänen A, Norrmén C, Ivanov KI, Andersson LC, Haglund C, Puolakkainen P, Wempe F, von Mechner H, Gradwohl G, Vanharanta S, Aaltonen LA, Saharinen J, Gentile M, Clarke A, Taipale J, Oliver G, Alitalo K (2008) Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell 13: 407-419 (Pubitemid 351609440)
16. Rodriquez-Niedenführ M, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Tomarev SI, Wilting J (2001) Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol (Berl) 204: 399-406 (Pubitemid 33139877)
17. Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP, Batlle E, Simon-Assmann P, Clevers H, Nathke IS, Clarke AR, Winton DJ (2004) Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18: 1385-1390 (Pubitemid 38780625)
18. Segditsas S, Tomlinson I (2006) Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537 (Pubitemid 44885752)
19. Shimoda M, Takahashi M, Yoshimoto T, Kono T, Ikai I, Kubo H (2006) A homeobox protein, PROX1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma. Clin Cancer Res 12: 6005-6011 (Pubitemid 44703761)
20. Sosa-Pineda B, Wigle JT, Oliver G (2002) Hepatocyte migration during liver development requires PROX1. Nat Genet 25: 254-255 (Pubitemid 30437306)
21. Wigle JT, Oliver G (1999) PROX1 function is required for the development of the murine lymphatic system. Cell 98: 769-778 (Pubitemid 29446894)
22. Yoneda Y (2000) Nucleocytoplasmic protein traffic and its significance to cell function. Genes Cells 5: 777-787